Vector Science & Therapeutics

Vector Science & Therapeutics is a biotechnology company focused on developing next-generation adeno-associated virus (AAV) vectors for gene therapy applications. Co-founded by gene therapy pioneer Dr. Guangping Gao, the company leverages advanced vector engineering to improve the safety, efficacy, and tissue-specificity of genetic medicines. Their platform is designed to address the current challenges of AAV delivery, including pre-existing immunity and off-target effects. By optimizing vector capsids and expression cassettes, Vector Science & Therapeutics aims to provide transformative treatments for patients with rare and complex diseases. The company operates in close collaboration with academic research centers to translate scientific breakthroughs into clinical solutions.